IncellDx Closes $3M Series A Financing

Proceeds will be used to further commercialize IncellDx's products and initiate the US clinical trial for its HPV OncoTect, which the company said may provide improved specificity over current tests.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories